Literature DB >> 28164890

A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms.

Wafa Saidi1, Ines Lahouel1, Molka Laarif1, Amina Aounallah1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28164890     DOI： 10.4103/0378-6323.198452

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  3 in total

Review 1.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

Review 2.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

3.  Successful Treatment of Imatinib-Induced DRESS Syndrome Using Reslizumab without Cessation of Imatinib: A Case Report.

Authors:  Hyerin Park; Gil-Soon Choi; Eun Mi Lee
Journal:  Case Rep Oncol       Date:  2021-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.